BUND FINANCE

BUND FINANCE › Stocks › ABT

Abbott Laboratories (ABT)

NYSE · Stock price, chart and technical analysis

US$103.97-0.5100 (-0.49%)

Data from Financial Modeling Prep · Nov 19, 2026, 4:00 PM New York time · may be delayed

Open the live chartSee Technicals⏱ Analyze entryQuarterly earnings📅 See in calendar💬 Explain this move⇄ ComparePractice in the Simulator

Key stats

Previous closeUS$104.48
OpenUS$104.93
Day rangeUS$103.61 – US$105.84
52-week rangeUS$81.97 – US$129.85
Market capUS$180.07B
Volume7.29M
50-day averageUS$103.86
200-day averageUS$101.50
Beta0.54
Last dividend per shareUS$2.52

Quick technical read

This describes price action; it is not a recommendation. The app also calculates RSI, MACD, the entry setup and 30+ indicators. How we calculate it

Fundamentals Annual

Fiscal year20212022202320242025
RevenueUS$43.1BUS$43.7BUS$40.1BUS$42.0BUS$44.3B
Net incomeUS$7.1BUS$6.9BUS$5.7BUS$13.4BUS$6.5B
EPS (diluted)3.943.913.277.643.72
Gross margin53.9%51.1%50.0%50.8%55.5%
Operating margin21.4%19.2%16.0%16.3%18.2%
Net margin16.4%15.9%14.3%32.0%14.7%
Free cash flowUS$8.6BUS$7.8BUS$5.1BUS$6.4BUS$7.4B
Total debtUS$19.3BUS$17.9BUS$15.9BUS$15.3BUS$15.1B
CashUS$9.8BUS$9.9BUS$6.9BUS$7.6BUS$8.5B

Compound annual growth: revenue 0.7% · net income -2.0% (4 years).

Valuation: today, its history and its sector

Today5-year averageSector median (Healthcare)
P/E38.5x29.0x26.4x
EV / EBITDA18.7x19.0x16.3x
Operating margin15.0%—3.6%
Net margin9.8%—-0.0%
Debt / equity1.11—0.58

Source: annual financial statements from Financial Modeling Prep. “Today” uses the current price and the last 4 quarters. The sector median uses U.S. companies above US$300M market cap. A multiple above or below its history or sector is not a recommendation.

About Abbott Laboratories

SectorHealthcare
IndustryMedical - Devices
CountryUS
CEORobert Ford
Employees115,000
IPO date1980-03-17

Abbott Laboratories, along with its affiliated entities, is a global healthcare enterprise dedicated to the research, development, manufacturing, and worldwide distribution of a diverse portfolio of health solutions. The company operates through four primary divisions: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. In the Established Pharmaceutical Products segment, Abbott provides generic medications designed to treat a wide array of conditions, including pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorders, hormone replacement therapy, dysl…

www.abbott.com

Other stocks on BUND FINANCE

Not financial advice. BUND FINANCE publishes general information for educational purposes. Investing involves risk, including loss of capital. Legal notice